Background {#Sec1}
==========

Almost all patients will develop intra-abdominal adhesions after abdominal surgery \[[@CR1]--[@CR4]\]. The most common consequences are: more complex subsequent surgery, abdominal pain, small bowel obstruction (SBO), and infertility. A 35% readmission rate over 10 years after abdominal surgery has been reported to be directly or possibly related to adhesions \[[@CR1]\]. The risk of developing SBO that requires surgery varies from 1% after appendectomy \[[@CR5], [@CR6]\] to more than 10% after colectomy \[[@CR3], [@CR7]\]. About 20% of those who do develop SBO do so within the first postoperative year \[[@CR1], [@CR2], [@CR7]\]. Thereafter, there is a steady increase in prevalence for up to at least 10 years after the initial operation \[[@CR8]\]. There are conflicting reports on the optimal timing of surgery for small bowel obstruction. Most studies advocate early surgery in line with the Bologna guidelines for SBO \[[@CR9], [@CR10]\], to minimise morbidity and mortality, although some take a more conservative approach \[[@CR11]\].

There is a limited number of reports on direct outcome measures after SBO surgery. The studies that do exist involve relatively few patients \[[@CR12]\] or focus on older material \[[@CR13], [@CR14]\]. Thus, studies analysing the clinical course after surgery for SBO in larger cohorts in more recent time periods are needed.

The aim of this study was to describe the mechanisms of adhesive SBO, as well as its morbidity, mortality, and recurrence after surgery for SBO in a defined population.

Methods {#Sec2}
=======

This study included adult patients operated on for adhesive SBO in the Uppsala and Gävleborg regions. There were 341,977 inhabitants in Uppsala and 276,637 in Gävleborg, which together make up 6.5% of the Swedish population. Emergency surgery was performed in three hospitals in the regions (Gävle County Hospital, Hudiksvall Hospital and Uppsala University Hospital). The time period (1 Jan 2007 to 31 Dec 2011) was selected to get a cohort of sufficient size and a follow-up of at least 5 years.

A search for adult patients (≥ 18 years) possibly operated on for SBO was performed using operation and diagnostic codes (R10, K56, JAH, JAP, JFB, JFK, and JFL) in the computer-based medical record systems. Patients with specific causes for obstruction, other than adhesions, were excluded, whit the remainder making up the study group (Fig. [1](#Fig1){ref-type="fig"}). Medical records were then analysed based on a protocol. Co-morbidities, type procedure, and number of previous operations were noted. The obstructive mechanisms, as described in the operation charts, were noted and classified as fibrous bands or diffuse adhesions. Where there was a description of a combination of bands and diffuse adhesions, a closer analysis of the operation chart was performed to determine whether bands or diffuse adhesions were the main cause of obstruction. Fig. 1Overview diagram of inclusions and exclusions in the study population

The following short-term complications (≤30 days) were analysed: anastomotic leak (diagnosis with contrast enema, CT or re-operation), abscess (diagnosis with CT or ultrasound), wound infection, wound dehiscence, cardiovascular, pulmonary, and urinary tract infection (positive culture). Cardiovascular complications included myocardial infarction and arrythmias, while pulmonary complications included aspiration and pneumonia. ICU stays, re-operations and mortality were also noted. Complications within 30- days were classified based on Clavien-, grades 2--5 \[[@CR15]\]. Analysis of long-term complications (\> 30 days) was focused on hospitalisation and surgery for recurrent SBO (SBO defined as presence of at least two of the following symptoms: loss of stool or flatus, nausea/vomiting, abdominal distension, and radiology supporting SBO). Incisional hernia was noted if mentioned in the charts or in the radiological report.

Data from medical records were collected until 2017. Follow-up time was calculated from the SBO- operation to the last noted contact in records or death. The study was approved by the local ethical committee at Uppsala University (Dnr 2015/196) and registered at [ClinicalTrials.gov](http://clinicaltrials.gov) (NCT03534596, 2018-05-24).

Surgery {#Sec3}
-------

The three hospitals had similar clinical routines, but there was no written protocol for management of SBO. Patients without signs of strangulation were initially treated with nasogastric tube, intravenous fluids and analgesics. Patients with signs of strangulation underwent urgent surgery; the others were subjected to radiology. The surgeon managing the patient made the decision to operate and determined the timing of the operation, based on his or her judgement. Laparoscopic surgery for SBO was not in practice during the study period, so all patients had open surgery through midline incisions. Data were collected on type of procedure (division of band, adhesiolysis, bowel resection, by- pass, or stoma), anastomoses, bowel- injuries, bleeding, and operating time.

Statistical analysis {#Sec4}
--------------------

Demographic and clinical data were analysed using χ2 tests for categorical variables and t-tests for continuous variables or Mann-Whitney U-tests in the case of non-normal distributions. Fisher's exact test was used instead of the χ2 test when low expected counts were observed. Numbers are given as means and ranges unless otherwise stated. Data were analysed using the statistical package SPSS® version 25 for Windows® (SPSS, Chicago, IL, USA). A two-sided *P* value ≤0.05 was considered to be statistically significant. No power calculation was made.

Results {#Sec5}
=======

Patients {#Sec6}
--------

The search of medical records resulted in 3326 patients possibly operated for SBO. After exclusions, a study group of 402 patients was identified (Fig. [1](#Fig1){ref-type="fig"}). In all, 240 (60%) were women and 162 (40%) were men. The median age was 70 years (range 18--97 years). More than half of patients had some co-morbidity (Table [1](#Tab1){ref-type="table"}) with the most common being cardiovascular disease (hypertension and other arterial disease, cardiac disease, cerebro- vascular disease). The preoperative American Society of Anesthesiologist's (ASA) classification was 3 or 4 for 48% (Table [1](#Tab1){ref-type="table"}). Thirty-seven patients (9%) had a previous malignant abdominal disease, with 23 of them having undergone radiation therapy to the pelvis as part of cancer treatment (rectal, prostate, or gynaecological cancer). Abdominoperineal resection had been performed in seven, all of whom had undergone radiation therapy. There were no signs of recurrent cancer as a cause of recurrent SBO. Table 1Demographic data and co-morbidityPatients ***n*** = 402Gender M/F162/240 (40%/60%)Age, in years, median, (range)70 (18--97)\< 40 years37 (9%)\> 80 years99 (25%)Co- morbidity ASA 1--2204 (51%) ASA 3--4193 (48%) MD^a^5 (1%)Cardiovascular202 (50%)COPD^b^45 (11%)Diabetes36 (9%)Immunosuppression25 (6%)Any of the above232 (58%)^a^missing diagnoses, ^b^Chronic Obstructive Pulmonary Disease

Fifty patients (12%) had not undergone any abdominal surgery before the index operation whereas 189 (47%) had one previous abdominal operation (Table [2](#Tab2){ref-type="table"}). Nineteen of those with one previous abdominal operation had had it done laparoscopically, one (5%) of them later developed SBO and was admitted for 2 days of conservative management. Previous surgery for SBO had been performed in 30 patients (7.5%). There were no differences in demographic data or previous surgery between the two regions. Table 2Previous abdominal surgery in relation to index operation for SBONo previous abdominal operationsWomen ***n*** = 240Men ***n*** = 162All n = 402 022 (9%)28 (17%)50 (12%) 1106 (44%)83 (51%)189 (47%) 246 (19%)35 (22%)81 (20%) 347 (20%)13 (8%)60 (15%) ≥419 (8%)3 (2%)22 (6%)**Type of procedure**\* Appendectomy80 (33%)35 (22%)115 (29%) Colorectal60 (25%)50 (31%)110 (27%) Gynaecological106 (44%)0 (0%)106 (26%) Upper GI69 (29%)35 (22%)104 (26%) Surgery for SBO17 (7%)13 (8%)30 (7%)**Previous surgery within***n* = 218*n* = 134*n* = 352 1 year47 (22%)36 (27%)83 (24%) 1--2 years8 (4%)9 (7%)17 (5%) 2--5 years22 (10%)18 (13%)40 (11%) \>  5 years141 (65%)71 (53%)212 (60%)\*Many patients had several operations, meaning that the total exceeds 100%

Surgery {#Sec7}
-------

The mean annual number of SBO operation was 116 during the study period, adhesive SBO was the dominating cause, leading to 80 operations per year. Adhesive SBO surgery was performed on 13 per 100, 000 inhabitants and year and a total of 5963 days were recorded for hospital stays related to index surgery for SBO.

Almost all patients (391/402, 97%) underwent a CT- scan and most also had a contrast follow-through. All but one of the patients had some diagnostic radiology before surgery.

Nearly all patients (*n* = 384, 96%) underwent surgery after being admitted to the emergency department, but 18 (5%) patients underwent surgery in the postoperative phase after other abdominal surgery. Overall, patients were operated on at mean 3.4 days (0--86) after hospitalisation or SBO- diagnosis. A total of 78 (19%) patients underwent an operation on the day of admission and another 120 (30%) were operated on within 2 days of hospitalisation.

Delaying surgery more than 2 days after admission was related to more re-operations (15% vs. 8%, *p* = 0.046) compared to those operated in the first 2 days. Similarly, surgery later than 4 days after admission was related to more re-operations (17% vs. 9%, *p* = 0.024) and more wound dehiscence (9% vs. 4%, *p* = 0.037). Beyond that, the timing of surgery was not related to mortality, short- or long-term complications, or bowel resection frequency. Nearly one-third (*n* = 122) had a period of conservative treatment longer than 3 days. Bowel injury was common, see Table [3](#Tab3){ref-type="table"}. Table 3Bowel injury related to the number of previous laparotomiesBowel injuryNo bowel injuryTotal n = 402153 (38%)249 (62%)No. previous abdominal surgeries 0 (*n* = 50)7 (14%)43 (86%) 1 (*n* = 189)67 (35%)122 (65%) 2 (*n* = 81)40 (49%)41 (51%) 3 (*n* = 60)29 (48%)31 (52%) ≥ 4 (n = 22)10 (45%)12 (55%)Intraabdominal abscess22/153 (14%)22/249 (9%)Enterocutaneous fistula2 (1.3%)0

In all, 139 patients (35%) had bowel resections (137 small bowel resections and 5 ileocecal resections, some had both). The resection length varied from 2 to 300 cm. Anastomotic leak was noted in 4 of the 139 (2.9%) patients with an anastomosis. In another eight patients, a by-pass was performed, most often for dense diffuse adhesions or due to difficult anatomy.

Adhesive mechanisms {#Sec8}
-------------------

The most common obstructing mechanism was a fibrous band, which was found in 226 (56%) of the patients. This was also the dominating cause for SBO in patients without a history of laparotomy (44/50, 88%). Patients with diffuse adhesions had more co-morbidity, more previous abdominal surgery, and a longer period of conservative treatment before being operated on, compared with patients with band adhesions (Table [4](#Tab4){ref-type="table"}). A longer operation time, more bleeding and more bowel injuries were observed in the diffuse adhesion group (Table [4](#Tab4){ref-type="table"}). Table 4Preoperative data, early and long-term complications in relation to band or diffuse adhesions as the mechanism of SBOBand adhesion ***n*** = 226Diffuse adhesions ***n*** = 176*p*- valueAge (years)^b^66.7 ± 1866.8 ± 170.949Gender m/f83/14379/970.098ASA 1--2^a^125 (55%)79 (45%)0.027ASA 3--497 (44%)96 (55%)0.027No. previous operations^b^1.3 ± 1.11.8 ± 1.1\< 0.001Admission to surgery (days, mean)^b^2.5 ± 5.24.5 ± 8.5\< 0.001Bleeding (ml)^b^106 ± 194304 ± 447\< 0.001Operation time (min)^b^75 ± 43122 ± 74\< 0.001Bowel injury50 (22%)103 (59%)\< 0.001Any bowel resection71 (31%)68 (39%)0.131By-pass1 (0.4%)7 (4%)0.012**Early complications**99 (44%)92 (52%)0.092 Anastomotic leak (*n* = 139)0/71 (0%)4/68 (7%)0.055 Wound dehiscence7 (3%)12 (7%)0.081 Wound infection9 (4%)12 (7%)0.205 Intraabdominal infection21 (9%)23(13%)0.229 Aspiration8 (4%)7 (4%)0.818 Pneumonia21 (9%)11(6%)0.264 Myocardial infarction3 (1%)4 (2%)0.472 Arrythmia12 (5%)9 (5%)0.930 Urinary tract infection19 (8%)13 (7%)0.708 Clavien-Dindo 259 (26%)45 (26%)0.903 Clavien-Dindo 312 (5%)13 (7%)0.392 Clavien-Dindo 418 (8%)22 (12%)0.132 Clavien-Dindo 511 (5%)10 (6%)0.716 Postoperative stay (days)^b^8.7 ± 7.113.6 ± 13.2\< 0.001 Length of stay (days)^b^11.5 ± 7.719.1 ± 16.7\< 0.001**Late complications** SBO- admission33 (15%)39 (22%)0.050 SBO- admission days (mean)^b^1.9 ± 4.15.6 ± 11.90.002 No. times admission for SBO (range)0.44 (0--3)1.02 (0--12)0.004 SBO- surgery13 (5.8%)13 (7.4%)0.509 Hernia11 (5%)13 (7%)0.290 Deceased at follow-up73 (32%)85 (48%)0.001^a^ASA- class: 5 patients missing. ^b^Mean ± SD.

The postoperative stay and total length of stay were significantly longer in the diffuse adhesion group. Anastomotic leaks, and unspecified use of antibiotics were more frequent in this group, and more of these patients died during follow-up (Table [4](#Tab4){ref-type="table"}). Furthermore, diffuse adhesions were related to more admissions for SBO and longer hospital stay during follow-up, but not to surgery for SBO.

Early complications (≤ 30 days) {#Sec9}
-------------------------------

One hundred and ninety-one (48%) patients had an early postoperative complication (Table [5](#Tab5){ref-type="table"}). The most common complication was intra-abdominal infection which affected 44 (11%) patients. Age over 70 years was related to increased complication frequency (Table [5](#Tab5){ref-type="table"}). Neither gender nor number of previous laparotomies affected complications (data not shown). Patients with ASA- class 3--4 had a complication frequency of 122/193 (63%) compared with 69/204 (34%) for ASA- class 1--2 (*p* \< 0.001). Table 5Early and late complications in relation to age at surgeryAge \< 70 years *n* = 201Age ≥ 70 years n = 201p- valueAll *n* = 402**Early** Anastomotic leak (*n* = 139)4/66 (6.1%)0/73(0.0%)0.0484/139 (2.9%) Wound dehiscence4 (2.0%)15 (7.5%)0.01019 (4.7%) Wound infection14 (7.0%)7 (3.5%)0.11721 (5.2%) Intraabdominal infection21 (10.4%)23 (11.4%)0.74944 (10.9%) Aspiration5 (2.5%)10 (5.0%)0.18815 (32.7%) Pneumonia9 (4.5%)23 (11.4%)0.01032 (8.0%) Myocardial infarction0 (0.0%)7 (3.5%)0.0157 (1.7%) Arrythmia1 (0.5%)20 (10.0%)\< 0.00121 (5.2%) Urinary tract infection11 (5.5%)21 (10.4%)0.06532 (8.0%) Re-operation18 (9.0%)23 (11.4%)0.41041 (10.2%) Intensive care16 (8.0%)35 (17.4%)0.00451 (12.7%) ICU days^a^0.62 ± 3.50.91 ± 3.70.4330.76 ± 3.6 Postoperative stay (days)^a^10.2 ± 10.811.4 ± 10.30.24110.8 ± 10.5**Late** SBO-admission45 (22.4%)27 (13.4%)0.01972 (17.9%) No. times admission for SBO^a^0.9 ± 1.90.5 ± 0.90.0320.7 ± 1.5 SBO- admission days^a^4.3 ± 9.82.5 ± 6.60.1173.5 ± 8.5 SBO- surgery17 (8.5%)9 (4.5%)0.10526 (6.5%) Hernia15 (7.5%)9 (4.5%)0.20724 (6.0%) Deceased at follow-up32 (16%)126 (63%)\< 0.001158 (39%)^a^Mean ± SD

Forty-one (10%) patients had an early re-operation, including scheduled second look (*n* = 8), abdominal sepsis (*n* = 11), wound dehiscence (*n* = 13), recurrent/persistent SBO (*n* = 7), postoperative bleeding (n = 1), and severe abdominal pain (n = 1).

Fifty- one (13%) patients needed intensive care and they had an average stay of 6 (1--40) days.

Late complications (\> 30 days) {#Sec10}
-------------------------------

Median length of follow-up was 66 months (0--122). Total overall mortality was 39% (*n* = 158), with 21 patients dying in the 30-day postoperative period and 137 patients dying beyond 30 days (Fig. [2](#Fig2){ref-type="fig"}). The mean age for these patients at index surgery was 78 years and 83 of them (52%) were above 80 years. The majority (79%) were preoperatively classified as ASA 3--4. The most common causes of death were cardiovascular diseases, malignancies, and respiratory diseases. Median age at death was 83 (range 30--98) years. For three patients, the cause of death was clearly related to SBO: two died after surgery for recurrent SBO and one died during hospital stay and conservative treatment for SBO. Fig. 2Cumulative data for overall mortality, re-admissions, and surgery for SBO

At follow-up, 72 patients (17.9%) had been admitted to hospital 1--12 times for symptoms of SBO. Of 201 patients below 70 years of age, 45 were admitted (22.4%) compared with 27 (13.4%) among patients above the age of 70 (*p* = 0.019). However, follow-up was longer for patients with recurrent SBO (median 74 vs. 64 months, *p* = 0.0014). Number of previous laparotomies (1.8 vs. 1.5, *p* = 0.013), bowel injury (39/72 vs. 114/330, *p* = 0.003), operating time (median 95 vs.78 min, *p* = 0.006) and peri operative bleeding (median 100 vs. 50 ml, *p* = 0.034) were related to recurrent hospitalisation for SBO. Twenty- six patients (6.5%) underwent another laparotomy because of SBO. Incisional hernia was confirmed in 24 (6%) of the patients during follow-up. Six (1.5%) patients underwent surgery because of incisional hernia during the follow-up period.

Discussion {#Sec11}
==========

A striking finding in this study was the strong negative impact of diffuse adhesions causing an increased risk for complications, more complex surgery, a prolonged hospital stay, more future SBO episodes, and a shorter life span. In this study, diffuse adhesions were the cause of obstruction in nearly half of the patients. Adhesiolysis may be difficult in the case of diffuse adhesions: during surgery nearly 60% had bowel injuries and if resection was needed, there was a tendency for more anastomotic leaks. For individual patients, this might lead to more complications, but there were no differences overall in early complications compared with among patients with band adhesions. Fevang et al. found a 29% recurrence rate at 25 years, which rose to 40% in the subgroup with diffuse adhesions \[[@CR16]\]. On average patients with diffuse adhesions had undergone more previous laparotomies and also had a higher ASA classification. Anticipated difficult surgery and/or, co-morbidity with risk of complications or death are possible reasons that these patients had a longer period of conservative treatment. In addition, there may have been other mechanisms of selection which cannot be assessed in a retrospective study. There were more women undergoing surgery for SBO, most likely reflecting previous gynaecological surgery. Gender did not affect other data or outcome. Demographic data also showed that many patients were old with co-morbidities; 25% of patients were older than 80 years and nearly all of them had co-morbidities resulting in ASA class 3--4. Surgery and postoperative care for this group is a challenge when trying to avoid complications and mortality.

Definitions of complications vary, and even missing in some studies, making direct comparisons difficult. Both complications and mortality are related to age which must be taken into account when comparing different studies. The current complication rate of 48% seems reasonable in view of the age distribution and co-morbidity. Thirty- day mortality was 5.2% (all being above 70 years) which is comparable to rates in other studies \[[@CR13]\]. In this study, we had no increased mortality when bowel injury was present. Long-term mortality was unexpectedly high, but analysis of causes of death showed that all but three died from diseases not related to SBO (cardiovascular, respiratory, malignant disease). Age at death did not differ from that of the general population in Sweden.

There was a small inflow (*n* = 10) of patients from other regions during the study period. About one-third of these were specific referrals due to complicated co-morbidity (transplant and vascular). The outflow of patients could not be assessed, but empirically knowledge indicates that there is no systematic referral to other regions. Emergency surgery during holidays or travels would account for patients being operated on elsewhere. We think this number is small, meaning that data could be regarded as population-based.

Thirteen SBO operations per 100, 000 inhabitants and year were performed. This was, a somewhat higher frequency than previously reported by Kossi et al. and Tingstedt et al. \[[@CR17], [@CR18]\], but on the other hand, less than half of what Ray et al. and Ellis et al. \[[@CR1], [@CR19]\] reported. This discrepancy may be due to differences in study design and local traditions or selection mechanisms. Balancing between conservative treatment and surgery is difficult in patients without peritonitis or strangulation. An elderly patient with co-morbidity and not requiring emergency surgery will probably start with a conservative regimen to avoid the surgical trauma. In our study, about 20% of patients needed same- day surgery, which is about equal to the rate reported by Bauer et al. \[[@CR20]\]. Overall mean time to surgery was 3.4 days (including outliers). A possible risk of prolonged conservative treatment is that increasingly extensive resections are necessary. Surgery after more than 4 days after admission was related to more re-operations and wound dehiscence, but not to resections, mortality, or other complications. Since most SBO episodes resolve with conservative treatment \[[@CR21]\], the balance between conservative treatment and surgery and timing of surgery is best assessed in a prospective manner. The current recommendation of early surgery seems reasonable.

Recurrent SBO was 7% at 1 year and 18% overall during follow-up, a third of these patients required surgery. About half of the recurrences appeared within the first 2 years, but there was a cumulative increase during follow-up. In this cohort, the number of patients at risk of recurrent SBO was reduced by the high overall mortality. Patients younger than 70 years, with lower mortality, also had a higher incidence of recurrent SBO (22.4%). Therefore, prevention of adhesions at initial surgery and at secondary SBO surgery is desirable. Minimally invasive surgery has been associated with less formation of adhesions and recent reviews found a reduction of SBO events and surgery for SBO after laparoscopic colorectal surgery compared with after open surgery \[[@CR22], [@CR23]\]. The increasing reports of laparoscopic SBO- surgery are promising \[[@CR24]\]; however, such surgery seems to be most suitable for adhesive bands. There are several adhesion prevention substances on the market, some of which are in a form of a sheet or film, creating a localised protection area. To address the prevention of adhesions, use of fluids in the abdominal cavity might be more logical. One such fluid, icodextrin, shows a potential ability to reduce adhesions \[[@CR25], [@CR26]\] and has been reported as safe to use in colorectal surgery \[[@CR27]\].

Conclusion {#Sec12}
==========

In this population-based study of adhesive SBO, the incidence of surgery was 13 per 100, 000 inhabitants and year. About half of patients with SBO are elderly with co-morbidity which predisposes to postoperative complications and mortality. The mechanism of obstruction was a fibrous band in 56% and diffuse adhesions in 44%. Diffuse adhesions were related to difficult surgery and future SBO. Overall, nearly one-fifth of patients needed re-admission for recurrent SBO. Continued research for preventing SBO is desirable.

SBO

:   Small bowel obstruction

ASA

:   American Society of Anesthesiologist's

ICU

:   Intensive care unit

CT

:   Computerized tomography

Dnr

:   Register number

COPD

:   Chronic obstructive pulmonary disease

MD

:   Missing diagnosis
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